Serum magnesium: time for a standardized and evidence-based reference range.


Journal

Magnesium research
ISSN: 1952-4021
Titre abrégé: Magnes Res
Pays: England
ID NLM: 8900948

Informations de publication

Date de publication:
01 May 2021
Historique:
pubmed: 1 9 2021
medline: 14 1 2022
entrez: 31 8 2021
Statut: ppublish

Résumé

Magnesium deficiency can have serious health consequences. Low magnesium intake or low serum levels are risk factors for e.g. type 2 diabetes and cardiovascular diseases. Despite its scientifically recognized importance, too little attention is paid to magnesium in clinical practice. This may be due to the fact that there is no uniform and evidence-based reference range for serum magnesium as is the case for other electrolytes such as sodium and potassium. The serum magnesium concentration is also of a limited informative value, as it is maintained for a long time by releasing magnesium from body pools. A low serum magnesium is a definite sign of magnesium deficiency; however, values within the reference range do not rule out deficiencies. Nevertheless, serum magnesium should become part of routine diagnostics in order to be able to better detect deficiency states. For serum magnesium, a reference range of 0.75 to 0.95 mmol/L (1.82 to 2.31 mg/dL) can often be found. However, according to the current data situation, serum magnesium values of less than 0.85 mmol/L are associated with increased health risks. Therefore, the lower limit of the reference range should be raised to 0.85 mmol/L (2.07 mg/dL).

Identifiants

pubmed: 34463286
pii: mrh.2021.0486
doi: 10.1684/mrh.2021.0486
doi:

Substances chimiques

Magnesium I38ZP9992A
Potassium RWP5GA015D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

84-89

Auteurs

Oliver Micke (O)

Department of Radiation Therapy and Radiation Oncology, Franziskus Hospital, Bielefeld, Germany, President of the German Society for Magnesium Research e.V.

Jürgen Vormann (J)

Institute for Prevention and Nutrition, Ismaning, Germany.

Anton Kraus (A)

Verla-Pharm Arzneimittel, Tutzing, Germany.

Klaus Kisters (K)

Medical Clinic I, St. Anna Hospital Herne, Germany, Vice-President of the German Society for Magnesium Research e.V.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH